학술논문
A phase I dose-escalation study of DHES0815A, a HER2-targeting antibody-drug conjugate with a DNA monoalkylator payload, in patients with HER2-positive breast cancer
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15387445